[1] |
ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
[J]. China Oncology, 2022, 32(1): 1-12.
|
[2] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[3] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[4] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[5] |
YUAN Hao , JIANG Xiaofei , YOU Qinghua , ZHU Hongbo , YE Huiying , WU Wen , QIAN Fengyuan , ZHONG Ming , LI Yongping .
Clinical application of fine needle puncture Diff-Quik staining for the differentiation and protection of parathyroid glands in thyroid carcinoma surgery
[J]. China Oncology, 2021, 31(4): 302-307.
|
[6] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[7] |
WU Hongwen, MEI Yan, WANG Qiao, YUAN Jia, ZHAO Liwei.
The clinical value of serum MIP-1α and S-TK1 in the evaluation of postoperative radioactive 131 I treatment for thyroid carcinoma
[J]. China Oncology, 2021, 31(11): 1088-1095.
|
[8] |
SHEN Yujia , FU Xiaolong .
Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer
[J]. China Oncology, 2021, 31(11): 1115-1125.
|
[9] |
FAN Bo , QI Pan , SU Jianzhi , WEI Shufei , ZHANG Xuan , ZHANG Aili .
Baseline characteristics and survival analysis of patients with prostate cancer in the Fourth Hospital of Hebei Medical University
[J]. China Oncology, 2020, 30(8): 620-625.
|
[10] |
MAO Tiebo, CUI Jiujie, WANG Liwei.
Research progress in pancreatic cancer in 2019 from experimental study to clinical evaluation
[J]. China Oncology, 2020, 30(2): 81-89.
|
[11] |
LI Min, WEN Peng, QIAN Qiuqin, QIN Ang, ZENG Li, SHI Feng.
Clinical study of iodine-125 seeds implantation in the treatment of lymph node metastasis of radioactive iodine- refractory differentiated thyroid cancer
[J]. China Oncology, 2020, 30(2): 122-127.
|
[12] |
MU Zhuanzhuan , LI Zheng , ZHANG Xin , LIN Yansong .
The effect of empiric 131 I therapy in papillary thyroid cancer patients with pulmonary metastasis
[J]. China Oncology, 2020, 30(12): 991-995.
|
[13] |
REN Junling , CHEN Bin , TANG Xiaolei .
Research on the correlation between BMI and pathologic factors of papillary thyroid carcinoma
[J]. China Oncology, 2020, 30(12): 1041-1045.
|
[14] |
XU Xinyan , CHEN Jiayan , MAO Jingfang , FAN Min .
Radiotherapy for non-small cell lung cancer: evolution and development
[J]. China Oncology, 2020, 30(10): 777-784.
|
[15] |
LIU Mengqi, JI Shunrong, XU Xiaowu, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2019
[J]. China Oncology, 2020, 30(1): 1-10.
|